Hormonal Therapy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC
Conditions:   Premenopausal Breast Cancer;   Metastatic Breast Cancer;   ER Positive Breast Cancer Interventions:   Drug: Goserelin;   Drug: Fulvestrant;   Drug: Capivasertib;   Drug: Durvalumab Sponsor:   National Taiwan University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2023 Category: Research Source Type: clinical trials

Effect of Menopausal Hormone Therapy on Immune System Parameters
Condition:   Last Period Not Earlier Than 6 Months Ago Interventions:   Drug: oral menopausal hormone therapy;   Drug: transdermal menopausal hormone therapy Sponsor:   Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2023 Category: Research Source Type: clinical trials